About: Common Cold and Acute Rhinosinusitis: Up-to-Date Management in 2020

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Common Cold and Acute Rhinosinusitis: Up-to-Date Management in 2020 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Common Cold and Acute Rhinosinusitis: Up-to-Date Management in 2020
Creator	Mullol, Joaquim Jaume, Francesca Valls-Mateus, Meritxell
topic	covid:d19f119cae8090d127b1b9ef6bee95e37b62c5b5#this
source	Medline; PMC
abstract	PURPOSE OF REVIEW: The purposes of the review are as follows: (1) to define acute rhinosinusitis (ARS) and their phenotypes, (2) to highlight the ARS management according to international guidelines, (3) to compare the physicians’ management with the ARS guideline recommendations, and (4) to report ARS socioeconomic burden. RECENT FINDINGS: Bacterial and non-bacterial ARS have similar symptoms, although they can be discriminated by using a combination of specific signs and symptoms. The prescription of antibiotics should be limited to clearly suspected bacterial ARS. There is an overuse of diagnosis tools and treatment prescriptions. The total cost per ARS episode in Europe is over €1000. SUMMARY: ARS is mainly an inflammatory disease triggered by viral infection, and few cases end up developing bacterial infection. In most of the cases, it is a self-resolving disease which diagnosis is mainly clinical and the treatment symptomatic. The incidence of complications is low and independent of antibiotic use. There is a high socioeconomic burden associated to ARS.
has issue date	2020-06-03(xsd:dateTime)
bibo:doi	10.1007/s11882-020-00917-5
bibo:pmid	32495003
has license	no-cc
sha1sum (hex)	d19f119cae8090d127b1b9ef6bee95e37b62c5b5
schema:url	https://doi.org/10.1007/s11882-020-00917-5
resource representing a document's title	Common Cold and Acute Rhinosinusitis: Up-to-Date Management in 2020
has PubMed Central identifier	PMC7266914
has PubMed identifier	32495003
schema:publication	Curr Allergy Asthma Rep
resource representing a document's body	covid:d19f119cae8090d127b1b9ef6bee95e37b62c5b5#body_text
is http://vocab.deri.ie/void#inDataset of	https://covidontheweb.inria.fr:4443/about/id/http/ns.inria.fr/covid19/d19f119cae8090d127b1b9ef6bee95e37b62c5b5
is schema:about of	named entity 'symptoms' named entity 'rhinosinusitis' named entity 'Europe' named entity 'cases' named entity 'Common Cold' named entity 'Acute' named entity 'define' named entity 'burden' named entity 'diagnosis' named entity 'antibiotic' named entity 'prescriptions' named entity 'inflammatory disease' named entity 'acute' named entity 'Recent' named entity 'compare' named entity 'ARS' named entity 'signs' named entity 'developing' named entity 'antibiotics' named entity 'inflammatory disease' named entity 'bacterial infection' named entity 'Common Cold' named entity 'erythema' named entity 'SARS-CoV-2 virus' named entity 'infection' named entity 'Cyclamen europaeum' named entity 'common cold' named entity 'viruses' named entity 'rhinovirus' named entity 'sinuses' named entity 'nasal congestion' named entity 'corticosteroid' named entity 'meningitis' named entity 'Streptococcus' named entity 'IDSA' named entity 'paranasal sinuses' named entity 'rhinosinusitis' named entity 'chronicity' named entity 'SARS-CoV-2 virus' named entity 'antibiotic' named entity 'primary care physicians' named entity 'diagnostic tools' named entity 'Netherlands' named entity 'mucosa' named entity 'CT scan' named entity 'pandemics' named entity 'over-diagnosis' named entity 'erythrocyte' named entity 'ABRS' named entity 'viruses' named entity 'imaging modality' named entity 'symptom' named entity 'loss of color vision' named entity 'PCR test' named entity 'Andrographis paniculata' named entity 'nasal discharge' named entity 'rhinorrhea' named entity 'primary care physicians' named entity 'phenotypes' named entity 'drug prescriptions' named entity 'social distancing' named entity 'viral infection' named entity 'acute rhinosinusitis' named entity 'erythrocyte sedimentation rate' named entity 'regular exercise' named entity 'common cold' named entity 'safe and effective' named entity 'periorbital edema' named entity 'short-term' named entity 'analgesics' named entity '38°C' named entity 'symptomatic treatment' named entity 'COVID' named entity 'intravenous' named entity 'self-limited' named entity 'inflammatory condition' named entity 'allergic rhinitis'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software